Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice the first effects of weight loss injections within one to two weeks of their starting dose — usually a reduced appetite rather than movement on the scales. Meaningful weight loss typically becomes visible after four to eight weeks, with the most substantial changes occurring over months of continued treatment. These are prescription-only medicines; a GPhC-registered prescriber needs to assess whether they are clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it is a Thursday evening, you have taken your first injection two days ago, and you realise you are leaving half a plate of pasta. That is usually the first signal. Both tirzepatide (Mounjaro) and semaglutide (Wegovy) work partly by slowing how quickly the stomach empties and signalling fullness to the brain, effects that can surface within days of the starting dose. The scales, though, are rarely cooperative yet. Water retention, gut content and normal daily fluctuation all mask early fat loss. So the first week tends to feel like a change in relationship with food rather than a change in body composition.
The starting doses are deliberately modest. Tirzepatide begins at 2.5 mg and semaglutide at 0.25 mg, these doses are there to let your body adjust and keep side effects manageable, not to produce rapid weight loss. If you are asking how long weight loss injections take to work in terms of visible results, week one is not the right window to judge by. Most people lose very little in those first seven days, and that is entirely expected.
For a fuller picture of what the medicine is actually doing during this phase, the mechanism behind weight loss injections is explained in plain terms on our education pages.
By the end of the first month, most patients on a GLP-1 medicine have reached a higher dose and the combined effect of reduced appetite and slower gastric emptying begins to show on the scales. Clinical trial data give a useful reference point here. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants taking tirzepatide lost an average of roughly 5% of their body weight by around week 12, before the higher maintenance doses had even been reached. The STEP 1 semaglutide trial showed a similar early trajectory.
Several things shape how quickly results arrive for any individual. Starting weight matters: someone with more to lose often sees faster early movement. Diet and activity make a real difference too; the medicine reduces appetite, but pairing that with adequate protein and regular movement accelerates progress and protects muscle mass. Sleep quality, stress, and underlying medical conditions all play a part. None of this is a reflection of effort or willpower, it is physiology.
You can read more about whether weight loss injections actually work, including the trial evidence, on a dedicated page. For a broader overview of the treatment options themselves, our guide to weight loss injections in the UK covers both Mounjaro and Wegovy in one place.
The headline figures that get quoted most often (around 20–21% average body weight reduction for tirzepatide at the highest dose in SURMOUNT-1, and around 15% for semaglutide 2.4 mg in STEP 1) were measured at 72 weeks and 68 weeks respectively. Not 12 weeks. That matters, because the dose titration schedule means most patients only reach the full maintenance dose roughly halfway through the first year of treatment. Progress is a curve, not a straight line, and it tends to steepen as the dose increases.
NHS guidance on weight management injections, published by NHS England, makes clear that these medicines are designed to be used alongside lifestyle changes over a sustained period. Expecting the full effect after six weeks is like judging a marathon runner by their first mile. Most clinicians look for at least 5% body weight reduction after six months at the highest tolerated dose as a marker that treatment is working well.
Cost is one of the practical factors people weigh up at this stage. If you are thinking about the longer commitment and what it involves financially, our page on weight loss injection prices in the UK sets out what is typically included in a private prescription and what to watch for when comparing providers.
A question our prescribers hear regularly: "I have been on it for six weeks and I have only lost three kilograms, is something wrong?" Usually the answer is no. Three kilograms in six weeks, if you are at a modest dose and have not yet titrated up, is within the normal range. The medicine takes time to reach its full effect, and individual variation is genuinely wide.
A few things can blunt the response. Constipation (one of the more common side effects) can add weight to the scales without representing fat. High calorie-dense drinks can offset the appetite reduction. And some people simply respond more slowly, for reasons that are not fully understood. If progress has stalled for several weeks at a stable dose, the right move is a conversation with your prescriber, not a guess at changing something yourself. The NHS tirzepatide medicines page at nhs.uk/medicines/tirzepatide has a clear summary of what to expect and when to seek advice.
If you are still weighing up whether an injection-based treatment suits your situation, our weight loss overview covers the full picture, and how fast weight loss injections work digs further into the pace of change for different patients. When you are ready to talk to a prescriber, starting a free consultation is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.